Abstract
Acute inflammation and the innate immune response to tissue trauma mark a critical pathophysiological challenge within the clinical course of severely injured and critically ill patients. Among the most potent cellular components of the innate host defense system are dendritic cells (DC). This highly effective network of antigen-presenting cells (APC) carries the ability to initiate and amplify diverse immune responses in respect of an appropriate activation signal. Upon activation, DCs direct the immune response towards developing either a Th1 or Th2 response, thus determining the outcome of the inflammatory or infectious stimulus. Advances in the understanding of DC immunobiology have provided new concepts in the treatment of various inflammatory diseases. With gene therapy constantly evolving new methods of celltargeted manipulation of gene expression, DCs have proven to be an exciting new tool in functionally modulating the immune response. In this review we summarize the pivotal functions of DCs and highlight their promising potency of representing an effective immunotherapeutic tool in the treatment of acute inflammation.
Keywords: Toll-like receptors, systemic inflammatory response, proinflammatory cytokines, lethal endotoxin, sepsis
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry
Title: Dendritic Cell Immunotherapy for Acute Inflammatory Diseases
Volume: 6 Issue: 2
Author(s): S. K. Tschoeke and A. Oberholzer
Affiliation:
Keywords: Toll-like receptors, systemic inflammatory response, proinflammatory cytokines, lethal endotoxin, sepsis
Abstract: Acute inflammation and the innate immune response to tissue trauma mark a critical pathophysiological challenge within the clinical course of severely injured and critically ill patients. Among the most potent cellular components of the innate host defense system are dendritic cells (DC). This highly effective network of antigen-presenting cells (APC) carries the ability to initiate and amplify diverse immune responses in respect of an appropriate activation signal. Upon activation, DCs direct the immune response towards developing either a Th1 or Th2 response, thus determining the outcome of the inflammatory or infectious stimulus. Advances in the understanding of DC immunobiology have provided new concepts in the treatment of various inflammatory diseases. With gene therapy constantly evolving new methods of celltargeted manipulation of gene expression, DCs have proven to be an exciting new tool in functionally modulating the immune response. In this review we summarize the pivotal functions of DCs and highlight their promising potency of representing an effective immunotherapeutic tool in the treatment of acute inflammation.
Export Options
About this article
Cite this article as:
Tschoeke K. S. and Oberholzer A., Dendritic Cell Immunotherapy for Acute Inflammatory Diseases, Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry 2007; 6 (2) . https://dx.doi.org/10.2174/187152307780598117
DOI https://dx.doi.org/10.2174/187152307780598117 |
Print ISSN 1871-5230 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-614X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Intracellular Drug Delivery: Mechanisms for Cell Entry
Current Pharmaceutical Design The Neurovascular Protection Afforded by Delayed Local Hypothermia after Transient Middle Cerebral Artery Occlusion
Current Neurovascular Research NF-κB as a Key Mediator of Brain Inflammation in Alzheimer’s Disease
CNS & Neurological Disorders - Drug Targets Efficient Chemical Synthesis of a Scutellarein Derivative Containing Morpholine Ring
Letters in Organic Chemistry Effects of Intravenous Apo A-I, HDLs and Apo A-I/Phospholipid Discs on Vascular Metabolism and Atherosclerosis in Animals and Humans
Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents Histamine and Histaminergic Receptors in Colorectal Cancer: From Basic Science to Evidence-based Medicine
Anti-Cancer Agents in Medicinal Chemistry Patent Selections
Recent Patents on Cardiovascular Drug Discovery Hormetic Potential of Sulforaphane (SFN) in Switching Cells’ Fate Towards Survival or Death
Mini-Reviews in Medicinal Chemistry Role of Nitric Oxide in Physiology and Pathology of the Gastrointestinal Tract
Mini-Reviews in Medicinal Chemistry Understanding and Modulating the Toll Like Receptors (TLRs) and NOD Like Receptors (NLRs) Cross Talk in Type 2 Diabetes
Current Diabetes Reviews Anti-inflammatory Sulfur-Containing Agents with Additional Modes of Action
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Recent Updates on Current and Upcoming Biomarkers for Cardiovascular Diseases
Current Pharmaceutical Design Favorable Effects of Astaxanthin on Brain Damage due to Ischemia- Reperfusion Injury
Combinatorial Chemistry & High Throughput Screening Clinical Aspects and Therapeutic Perspectives of Relaxin
Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents Snake Venom Proteins Isolated from Tunisian Vipers: Pharmacological and Therapeutic Overview
Venoms and Toxins Effect of TRAF1 on Phenotypic Changes Of Kupffer Cells In Liver Transplantation Ischemic-Reperfusion
Current Pharmaceutical Biotechnology Clinical Applications of Cardiac Multi-Slice Computed Tomography
Current Medical Imaging Gene Therapy in Liver Ischemia and Reperfusion Injury
Current Pharmaceutical Design Inspired Nitric Oxide and Modulation of Oxidative Stress During Cardiac Surgery
Current Drug Safety The Toll-Like Receptor Radical Cycle Pathway: A New Drug Target in Immune-Related Chronic Fatigue
CNS & Neurological Disorders - Drug Targets